Seung Mo Ham

Title: Seung Mo Ham: Innovator in Pharmaceutical Chemistry

Introduction

Seung Mo Ham is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain. With a total of 4 patents to his name, his work is paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents involves imidazopyrimidine and imidazotriazine derivatives, along with a pharmaceutical composition comprising these compounds. The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof. This compound acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5). It is particularly useful in the prevention or treatment of disorders mediated by glutamate dysfunction and mGluR5.

Career Highlights

Seung Mo Ham is currently associated with SK Biopharmaceuticals Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to the creation of compounds that have the potential to significantly impact the treatment of neurological disorders.

Collaborations

Throughout his career, Seung Mo Ham has collaborated with notable colleagues, including Chun Eung Park and Young Koo Jang. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Seung Mo Ham's contributions to pharmaceutical chemistry exemplify the importance of innovation in medical science. His work not only advances our understanding of receptor modulation but also holds promise for future therapeutic applications.